Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD · Real-Time Price · USD
1.250
-0.690 (-35.57%)
At close: Jun 27, 2025, 4:00 PM
1.180
-0.070 (-5.60%)
After-hours: Jun 27, 2025, 7:59 PM EDT
Aethlon Medical Employees
Aethlon Medical had 14 employees as of March 31, 2024. The number of employees decreased by 1 or -6.67% compared to the previous year.
Employees
14
Change (1Y)
-1
Growth (1Y)
-6.67%
Revenue / Employee
n/a
Profits / Employee
-$956,292
Market Cap
3.23M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AEMD News
- 1 day ago - Aethlon Medical, Inc. (AEMD) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Aethlon Medical Announces Financial Results for the Fiscal Fourth Quarter Ended March 31, 2025, and Provides Corporate Update - PRNewsWire
- 7 days ago - Aethlon Medical to Release Fiscal Fourth Quarter Financial Results and Host Conference Call on June 26, 2025 - PRNewsWire
- 9 days ago - Aethlon Medical Treats Second Patient in Australian Hemopurifier® Cancer Trial - PRNewsWire
- 18 days ago - Aethlon Medical to Present New Pre-Clinical Data at the Keystone Symposium on Long COVID and Other Post-Acute Infection Syndromes - PRNewsWire
- 6 weeks ago - Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Platelet-Derived Extracellular Vesicles from Plasma - PRNewsWire
- 3 months ago - Aethlon Medical Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology Journal - PRNewsWire
- 4 months ago - Aethlon Medical to Present at the Emerging Growth Conference on February 19, 2025 - PRNewsWire